|
Name |
Xenoacremone E
|
| Molecular Formula | C29H33NO6 | |
| IUPAC Name* |
4-ethenyl-5,19-dihydroxy-9,11-dimethyl-15,21-dioxa-23-azaheptacyclo[17.2.2.216,19.13,7.01,20.08,13.014,27]hexacosa-6,16(25),17,26-tetraene-2,22-dione
|
|
| SMILES |
C=CC1C(O)C=C2C3CC(C)CC(C)C3C3Oc4ccc(cc4)CC4(O)NC(=O)C5(OC45)C(=O)C1C23
|
|
| InChI |
InChI=1S/C29H33NO6/c1-4-17-20(31)11-19-18-10-13(2)9-14(3)21(18)24-22(19)23(17)25(32)29-26(36-29)28(34,30-27(29)33)12-15-5-7-16(35-24)8-6-15/h4-8,11,13-14,17-18,20-24,26,31,34H,1,9-10,12H2,2-3H3,(H,30,33)/t13-,14+,17-,18+,20-,21-,22+,23-,24-,26-,28-,29-/m1/s1
|
|
| InChIKey |
ZZGLZMUCFNPITP-YENVCKQNSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 491.58 | ALogp: | 2.2 |
| HBD: | 3 | HBA: | 6 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 108.4 | Aromatic Rings: | 8 |
| Heavy Atoms: | 36 | QED Weighted: | 0.317 |
| Caco-2 Permeability: | -4.977 | MDCK Permeability: | 0.00008560 |
| Pgp-inhibitor: | 0.047 | Pgp-substrate: | 0.026 |
| Human Intestinal Absorption (HIA): | 0.417 | 20% Bioavailability (F20%): | 0.071 |
| 30% Bioavailability (F30%): | 0.05 |
| Blood-Brain-Barrier Penetration (BBB): | 0.176 | Plasma Protein Binding (PPB): | 96.27% |
| Volume Distribution (VD): | 2.486 | Fu: | 3.68% |
| CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.757 |
| CYP2C19-inhibitor: | 0.134 | CYP2C19-substrate: | 0.893 |
| CYP2C9-inhibitor: | 0.086 | CYP2C9-substrate: | 0.06 |
| CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.261 |
| CYP3A4-inhibitor: | 0.904 | CYP3A4-substrate: | 0.9 |
| Clearance (CL): | 9.918 | Half-life (T1/2): | 0.023 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.337 |
| Drug-inuced Liver Injury (DILI): | 0.959 | AMES Toxicity: | 0.136 |
| Rat Oral Acute Toxicity: | 0.996 | Maximum Recommended Daily Dose: | 0.897 |
| Skin Sensitization: | 0.024 | Carcinogencity: | 0.493 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
| Respiratory Toxicity: | 0.94 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005135 | ![]() |
0.681 | D0VA0I | ![]() |
0.229 | ||
| ENC005366 | ![]() |
0.570 | D0W2EK | ![]() |
0.211 | ||
| ENC003606 | ![]() |
0.570 | D06OMK | ![]() |
0.208 | ||
| ENC003989 | ![]() |
0.561 | D01XDL | ![]() |
0.206 | ||
| ENC005768 | ![]() |
0.522 | D0H0SJ | ![]() |
0.204 | ||
| ENC005766 | ![]() |
0.493 | D0Z4UN | ![]() |
0.199 | ||
| ENC005769 | ![]() |
0.492 | D06WTZ | ![]() |
0.199 | ||
| ENC005770 | ![]() |
0.492 | D0H0ND | ![]() |
0.196 | ||
| ENC003349 | ![]() |
0.467 | D01XWG | ![]() |
0.193 | ||
| ENC003137 | ![]() |
0.457 | D0V3ZA | ![]() |
0.191 | ||